P3 Health Partners Inc (PIII)
0.55
+0.08
(+17.45%)
USD |
NASDAQ |
Apr 30, 16:00
0.55
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Enterprise Value: 419.42M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 419.42M |
| April 26, 2024 | 416.78M |
| April 25, 2024 | 420.80M |
| April 24, 2024 | 423.23M |
| April 23, 2024 | 424.75M |
| April 22, 2024 | 425.85M |
| April 19, 2024 | 423.87M |
| April 18, 2024 | 423.32M |
| April 17, 2024 | 423.21M |
| April 16, 2024 | 419.84M |
| April 15, 2024 | 422.36M |
| April 12, 2024 | 433.31M |
| April 11, 2024 | 434.58M |
| April 10, 2024 | 438.84M |
| April 09, 2024 | 448.10M |
| April 08, 2024 | 457.29M |
| April 05, 2024 | 459.83M |
| April 04, 2024 | 461.25M |
| April 03, 2024 | 457.83M |
| April 02, 2024 | 458.04M |
| April 01, 2024 | 469.12M |
| March 28, 2024 | 486.45M |
| March 27, 2024 | 485.25M |
| March 26, 2024 | 473.57M |
| March 25, 2024 | 485.25M |
| Date | Value |
|---|---|
| March 22, 2024 | 481.52M |
| March 21, 2024 | 491.22M |
| March 20, 2024 | 473.92M |
| March 19, 2024 | 480.49M |
| March 18, 2024 | 478.90M |
| March 15, 2024 | 485.25M |
| March 14, 2024 | 445.92M |
| March 13, 2024 | 457.98M |
| March 12, 2024 | 482.45M |
| March 11, 2024 | 484.78M |
| March 08, 2024 | 491.78M |
| March 07, 2024 | 496.44M |
| March 06, 2024 | 489.45M |
| March 05, 2024 | 498.77M |
| March 04, 2024 | 491.78M |
| March 01, 2024 | 485.95M |
| February 29, 2024 | 484.78M |
| February 28, 2024 | 485.95M |
| February 27, 2024 | 490.61M |
| February 26, 2024 | 489.45M |
| February 23, 2024 | 483.62M |
| February 22, 2024 | 483.62M |
| February 21, 2024 | 485.95M |
| February 20, 2024 | 485.95M |
| February 16, 2024 | 484.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
318.58M
Minimum
Dec 28 2021
2.068B
Maximum
Mar 22 2022
1.051B
Average
965.70M
Median
Aug 09 2023
Enterprise Value Benchmarks
| American Shared Hospital Services | 28.12M |
| Novo Integrated Sciences Inc | 15.20M |
| Astrana Health Inc | 1.479B |
| Cryo-Cell International Inc | 77.55M |
| Biote Corp | 215.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.46M |
| Revenue (Quarterly) | 346.86M |
| Total Expenses (Quarterly) | 411.12M |
| EPS Diluted (Quarterly) | -0.24 |
| Profit Margin (Quarterly) | -7.34% |
| Earnings Yield | -121.8% |
| Normalized Earnings Yield | -122.44 |